Increased immunoreactive calcitonin in idiopathic hypercalciuria

J. L. Ivey, B. A. Roos, F. H. Shen, D. J. Baylink

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Serum immunoreactive calcitonin concentration (iCT) was determined in nine subjects with idiopathic hypercalciuria (IH), prior to and during oral phosphate supplementation (500 mg qid) to test the hypothesis that a renal phosphate leak was the primary defect resulting in IH in these patients. Prior to the oral phosphate supplementation, serum ICT was significantly elevated in the IH group, when compared to 26 normal individuals (75 ± 7 vs 45± 4 pg/ml, mean ± SE, P < .001). During oral phosphate treatment, however, serum iCT decreased to levels not significantly different from normals (39 ± 3 and 50 ± 5 pg/ml after 4 and 8 weeks, respectively). When data prior to and during phosphate supplementation were pooled, there was a significant correlation (r = .70, N = 26, P < .001) between serum iCT and serum calcium. These observations suggest that the increased serum iCT in these subjects was a response to slight elevations in serum calcium, which are the result of normal physiological mechanisms to correct the renal phosphate leak.

Original languageEnglish (US)
Pages (from-to)39-42
Number of pages4
JournalMetabolic Bone Disease and Related Research
Issue number1
StatePublished - 1981


  • Calcitonin
  • Idiopathic Hypercalciuria
  • Oral Phosphate
  • Renal Phosphate Leak

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Surgery


Dive into the research topics of 'Increased immunoreactive calcitonin in idiopathic hypercalciuria'. Together they form a unique fingerprint.

Cite this